4. Lipids

doi:10.1097/01.mpg.0000181844.08876.7c

Cited by 4 publications

(1 citation statement)

References 111 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We can safely assume that most of the children aged 0–2 years are breastfed or receive some kind of milk formula. In this age group that is fed either human milk or formula, triglyceride concentrations are often high (150 mg/dL to 200 mg/dL) [ 22 , 23 , 24 ]. The very high mean value of triglycerides in the youngest group can be explained by their feeding habits and timing.…”

Section: Discussionmentioning

confidence: 99%

Dyslipidemia in Pediatric Patients: A Cross-Sectional Study

et al. 2023

View full text Add to dashboard Cite

There is an increasing interest in dyslipidemia in adult patients since it is known to contribute to early cardiovascular disease. Often, dyslipidemia starts in childhood, and it is associated with aggravating lifestyle choices concerning eating habits, such as the tendency to consume processed food and fast food, as well as the tendency to be more and more sedentary. We conducted a retrospective cross-sectional study describing the prevalence of dyslipidemia in a single medical center in Romania and the associated pathology. We evaluated all lipid profiles that were ordered in our clinic over nine years. We included 2413 patients that were evaluated in our clinic in the timeframe 2011–2020. Out of them, 18.23% had high values for LDL-cholesterol. More than a quarter (25.91%) were diagnosed with obesity. 11.37% of the patients with high LDL-cholesterol levels had various metabolic disorders including primary dyslipidemia. A small number of patients with hypercholesterolemia had thyroid disorders (4.10%). Patients with high LDL-cholesterol had various diagnoses ranging from metabolic to neurologic disorders, keeping in mind that there are multiple pathologies that can lead to dyslipidemia. Evaluating children for dyslipidemia is at hand for medical professionals. Screening for dyslipidemia in children would provide the opportunity to prevent rather than treat cardiovascular events.

show abstract

Section: Discussionmentioning

confidence: 99%

Dyslipidemia in Pediatric Patients: A Cross-Sectional Study

et al. 2023

View full text Add to dashboard Cite

show abstract

Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology

Driscoll¹,

Bistrian²,

Demmelmair³

et al. 2008

Clinical Nutrition

View full text Add to dashboard Cite

Lipids and Fatty Acids in the Preterm Infant, Part 1: Basic Mechanisms of Delivery, Hydrolysis, and Bioavailability

Martin

2015

NeoReviews

View full text Add to dashboard Cite

Lipids represent a diverse class of organic compounds that are critical for optimal nutrition, growth, and development. Fatty acids are the major building blocks for these compounds, and their structural configuration defines their bioactive potential in optimizing cell membrane structure and function. Activation and metabolism of membrane-bound long-chain polyunsaturated fatty acids lead to the production of terminal metabolites that have diverse properties in regulating inflammation and organogenesis and thus are critical in maintaining global health. This article (part 1) provides a review of basic mechanisms in lipid and fatty acid delivery, hydrolysis, and bioavailability. Part 2 highlights the special considerations for preterm infants in the pathways of lipid hydrolysis and fatty acid bioavailability, including their unique needs in polyunsaturated fatty acids.

show abstract

4. Lipids

Cited by 4 publications

References 111 publications

Dyslipidemia in Pediatric Patients: A Cross-Sectional Study

Dyslipidemia in Pediatric Patients: A Cross-Sectional Study

Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology

Lipids and Fatty Acids in the Preterm Infant, Part 1: Basic Mechanisms of Delivery, Hydrolysis, and Bioavailability

Contact Info

Product

Resources

About